Skip to main content
Top
Published in: Clinical Research in Cardiology 8/2021

Open Access 01-08-2021 | Obesity | Original Paper

Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data

Authors: Nick Marcks, Alberto Aimo, James L. Januzzi Jr, Giuseppe Vergaro, Aldo Clerico, Roberto Latini, Jennifer Meessen, Inder S. Anand, Jay N. Cohn, Jørgen Gravning, Thor Ueland, Antoni Bayes-Genis, Josep Lupón, Rudolf A. de Boer, Akiomi Yoshihisa, Yasuchika Takeishi, Michael Egstrup, Ida Gustafsson, Hanna K. Gaggin, Kai M. Eggers, Kurt Huber, Ioannis Tentzeris, Andrea Ripoli, Claudio Passino, Sandra Sanders-van Wijk, Michele Emdin, Hans-Peter Brunner-La Rocca

Published in: Clinical Research in Cardiology | Issue 8/2021

Login to get access

Abstract

Background

Higher body mass index (BMI) is associated with better outcome compared with normal weight in patients with HF and other chronic diseases. It remains uncertain whether the apparent protective role of obesity relates to the absence of comorbidities. Therefore, we investigated the effect of BMI on outcome in younger patients without co-morbidities as compared to older patients with co-morbidities in a large heart failure (HF) population.

Methods

In an individual patient data analysis from pooled cohorts, 5,819 patients with chronic HF and data available on BMI, co-morbidities and outcome were analysed. Patients were divided into four groups based on BMI (i.e. ≤ 18.5 kg/m2, 18.5–25.0 kg/m2; 25.0–30.0 kg/m2; 30.0 kg/m2). Primary endpoints included all-cause mortality and HF hospitalization-free survival.

Results

Mean age was 65 ± 12 years, with a majority of males (78%), ischaemic HF and HF with reduced ejection fraction. Frequency of all-cause mortality or HF hospitalization was significantly worse in the lowest two BMI groups as compared to the other two groups; however, this effect was only seen in patients older than 75 years or having at least one relevant co-morbidity, and not in younger patients with HF only. After including medications and N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin concentrations into the model, the prognostic impact of BMI was largely absent even in the elderly group with co-morbidity.

Conclusions

The present study suggests that obesity is a marker of less advanced disease, but does not have an independent protective effect in patients with chronic HF.

Graphic abstract

Categories of BMI are only predictive of poor outcome in patients aged > 75 years or with at least one co-morbidity (bottom), but not in those aged < 75 years without co-morbidities (top). The prognostic effect largely disappears in multivariable analyses even for the former group. These findings question the protective effect of obesity in chronic heart failure (HF).
Appendix
Available only for authorised users
Literature
1.
go back to reference Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. New Engl J Med 347(5):305–313. https://doi.org/10.1056/NEJMoa020245CrossRef Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. New Engl J Med 347(5):305–313. https://​doi.​org/​10.​1056/​NEJMoa020245CrossRef
8.
go back to reference Streng KW, Voors AA, Hillege HL, Anker SD, Cleland JG, Dickstein K, Filippatos G, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Zannad F, Damman K, van der Meer P, Lang CC (2018) Waist-to-hip ratio and mortality in heart failure. Eur J Heart Fail 20(9):1269–1277. https://doi.org/10.1002/ejhf.1244CrossRefPubMed Streng KW, Voors AA, Hillege HL, Anker SD, Cleland JG, Dickstein K, Filippatos G, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Zannad F, Damman K, van der Meer P, Lang CC (2018) Waist-to-hip ratio and mortality in heart failure. Eur J Heart Fail 20(9):1269–1277. https://​doi.​org/​10.​1002/​ejhf.​1244CrossRefPubMed
9.
go back to reference Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupon J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Tang WHW, Grodin J, Passino C, Emdin M (2018) Prognostic value of high-sensitivity troponin T in chronic heart failure: an individual patient data meta-analysis. Circulation 137(3):286–297. https://doi.org/10.1161/circulationaha.117.031560CrossRefPubMed Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupon J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Tang WHW, Grodin J, Passino C, Emdin M (2018) Prognostic value of high-sensitivity troponin T in chronic heart failure: an individual patient data meta-analysis. Circulation 137(3):286–297. https://​doi.​org/​10.​1161/​circulationaha.​117.​031560CrossRefPubMed
10.
go back to reference Aimo A, Januzzi JL Jr, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupon J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Ripoli A, Passino C, Emdin M (2019) Revisiting the obesity paradox in heart failure: Percent body fat as predictor of biomarkers and outcome. Eur J Prev Cardiol 26:1751–1759. https://doi.org/10.1177/2047487319852809CrossRefPubMed Aimo A, Januzzi JL Jr, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupon J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Ripoli A, Passino C, Emdin M (2019) Revisiting the obesity paradox in heart failure: Percent body fat as predictor of biomarkers and outcome. Eur J Prev Cardiol 26:1751–1759. https://​doi.​org/​10.​1177/​2047487319852809​CrossRefPubMed
11.
go back to reference Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, diSomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock WF, Spinar J, van Kimmenade R, Mebazaa A (2014) Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 63(8):778–785. https://doi.org/10.1016/j.jacc.2013.09.072CrossRefPubMed Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, diSomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock WF, Spinar J, van Kimmenade R, Mebazaa A (2014) Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 63(8):778–785. https://​doi.​org/​10.​1016/​j.​jacc.​2013.​09.​072CrossRefPubMed
15.
go back to reference Gentile F, Sciarrone P, Zamora E, De Antonio M, Santiago E, Domingo M, Aimo A, Giannoni A, Passino C, Codina P, Bayes-Genis A, Lupon J, Emdin M, Vergaro G (2020) Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction. Eur J Prev Cardiol. 2;2047487320927610. https://doi.org/10.1177/2047487320927610 Gentile F, Sciarrone P, Zamora E, De Antonio M, Santiago E, Domingo M, Aimo A, Giannoni A, Passino C, Codina P, Bayes-Genis A, Lupon J, Emdin M, Vergaro G (2020) Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction. Eur J Prev Cardiol. 2;2047487320927610. https://​doi.​org/​10.​1177/​2047487320927610​
16.
go back to reference Zamora E, Lupón J, Enjuanes C, Pascual-Figal D, de Antonio M, Domingo M, Comín-Colet J, Vila J, Peñafiel J, Farré N, Alonso N, Santesmases J, Troya M, Bayés-Genís A (2016) No benefit from the obesity paradox for diabetic patients with heart failure. Eur J Heart Fail 18(7):851–858. https://doi.org/10.1002/ejhf.576CrossRefPubMed Zamora E, Lupón J, Enjuanes C, Pascual-Figal D, de Antonio M, Domingo M, Comín-Colet J, Vila J, Peñafiel J, Farré N, Alonso N, Santesmases J, Troya M, Bayés-Genís A (2016) No benefit from the obesity paradox for diabetic patients with heart failure. Eur J Heart Fail 18(7):851–858. https://​doi.​org/​10.​1002/​ejhf.​576CrossRefPubMed
18.
go back to reference Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Janosi A, Kamensky G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J (2007) Rosuvastatin in older patients with systolic heart failure. New Engl J Med 357(22):2248–2261. https://doi.org/10.1056/NEJMoa0706201CrossRef Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Janosi A, Kamensky G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J (2007) Rosuvastatin in older patients with systolic heart failure. New Engl J Med 357(22):2248–2261. https://​doi.​org/​10.​1056/​NEJMoa0706201CrossRef
20.
go back to reference Fadini GP, Bonora BM, Marcuzzo G, Marescotti MC, Cappellari R, Pantano G, Sanzari MC, Duran X, Vendrell J, Plebani M, Avogaro A (2015) Circulating stem cells associate with adiposity and future metabolic deterioration in healthy subjects. J Clin Endocrinol Metab 100(12):4570–4578. https://doi.org/10.1210/jc.2015-2867CrossRefPubMed Fadini GP, Bonora BM, Marcuzzo G, Marescotti MC, Cappellari R, Pantano G, Sanzari MC, Duran X, Vendrell J, Plebani M, Avogaro A (2015) Circulating stem cells associate with adiposity and future metabolic deterioration in healthy subjects. J Clin Endocrinol Metab 100(12):4570–4578. https://​doi.​org/​10.​1210/​jc.​2015-2867CrossRefPubMed
24.
go back to reference Jackson AS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC, Skinner JS, Bouchard C, Wilmore JH (2002) The effect of sex, age and race on estimating percentage body fat from body mass index: The Heritage Family Study. Int J Obes Relat Metab Disorders J Int Assoc Study Obesity 26(6):789–796. https://doi.org/10.1038/sj.ijo.0802006CrossRef Jackson AS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC, Skinner JS, Bouchard C, Wilmore JH (2002) The effect of sex, age and race on estimating percentage body fat from body mass index: The Heritage Family Study. Int J Obes Relat Metab Disorders J Int Assoc Study Obesity 26(6):789–796. https://​doi.​org/​10.​1038/​sj.​ijo.​0802006CrossRef
26.
go back to reference Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361(9363):1077–1083. https://doi.org/10.1016/S0140-6736(03)12892-9CrossRef Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361(9363):1077–1083. https://​doi.​org/​10.​1016/​S0140-6736(03)12892-9CrossRef
35.
go back to reference Maeder MT, Mueller C, Pfisterer ME, Buser PT, Brunner-La Rocca HP (2008) Use of B-type natriuretic peptide outside of the emergency department. Int J Cardiol 127(1):5–16. https://doi.org/10.1016/j.ijcard.2007.10.018CrossRef Maeder MT, Mueller C, Pfisterer ME, Buser PT, Brunner-La Rocca HP (2008) Use of B-type natriuretic peptide outside of the emergency department. Int J Cardiol 127(1):5–16. https://​doi.​org/​10.​1016/​j.​ijcard.​2007.​10.​018CrossRef
37.
go back to reference Sanders-van Wijk S, van Empel V, Davarzani N, Maeder MT, Handschin R, Pfisterer ME, Brunner-La Rocca HP, investigators T-C (2015) Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs reduced left ventricular ejection fraction. Eur J Heart Fail 17(10):1006–1014. https://doi.org/10.1002/ejhf.414CrossRefPubMed Sanders-van Wijk S, van Empel V, Davarzani N, Maeder MT, Handschin R, Pfisterer ME, Brunner-La Rocca HP, investigators T-C (2015) Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs reduced left ventricular ejection fraction. Eur J Heart Fail 17(10):1006–1014. https://​doi.​org/​10.​1002/​ejhf.​414CrossRefPubMed
38.
go back to reference Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N, Loncar G, Springer J, Doehner W, Lainscak M, Hasenfuß G, Anker SD, von Haehling S (2018) Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur J Heart Fail 20(11):1580–1587. https://doi.org/10.1002/ejhf.1304CrossRefPubMed Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N, Loncar G, Springer J, Doehner W, Lainscak M, Hasenfuß G, Anker SD, von Haehling S (2018) Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur J Heart Fail 20(11):1580–1587. https://​doi.​org/​10.​1002/​ejhf.​1304CrossRefPubMed
39.
go back to reference Piepoli MF, Corrà U, Veglia F, Bonomi A, Salvioni E, Cattadori G, Metra M, Lombardi C, Sinagra G, Limongelli G, Raimondo R, Re F, Magrì D, Belardinelli R, Parati G, Minà C, Scardovi AB, Guazzi M, Cicoira M, Scrutinio D, Di Lenarda A, Bussotti M, Frigerio M, Correale M, Villani GQ, Paolillo S, Passino C, Agostoni P (2016) Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group. Eur J Heart Fail 18(5):545–553. https://doi.org/10.1002/ejhf.534CrossRefPubMed Piepoli MF, Corrà U, Veglia F, Bonomi A, Salvioni E, Cattadori G, Metra M, Lombardi C, Sinagra G, Limongelli G, Raimondo R, Re F, Magrì D, Belardinelli R, Parati G, Minà C, Scardovi AB, Guazzi M, Cicoira M, Scrutinio D, Di Lenarda A, Bussotti M, Frigerio M, Correale M, Villani GQ, Paolillo S, Passino C, Agostoni P (2016) Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group. Eur J Heart Fail 18(5):545–553. https://​doi.​org/​10.​1002/​ejhf.​534CrossRefPubMed
Metadata
Title
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data
Authors
Nick Marcks
Alberto Aimo
James L. Januzzi Jr
Giuseppe Vergaro
Aldo Clerico
Roberto Latini
Jennifer Meessen
Inder S. Anand
Jay N. Cohn
Jørgen Gravning
Thor Ueland
Antoni Bayes-Genis
Josep Lupón
Rudolf A. de Boer
Akiomi Yoshihisa
Yasuchika Takeishi
Michael Egstrup
Ida Gustafsson
Hanna K. Gaggin
Kai M. Eggers
Kurt Huber
Ioannis Tentzeris
Andrea Ripoli
Claudio Passino
Sandra Sanders-van Wijk
Michele Emdin
Hans-Peter Brunner-La Rocca
Publication date
01-08-2021
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 8/2021
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-021-01822-1

Other articles of this Issue 8/2021

Clinical Research in Cardiology 8/2021 Go to the issue